Abrogation of USP9X is a potential strategy to decrease PEG10 levels and impede tumor progression in cutaneous T-cell lymphoma
Article in Journal of Investigative Dermatology (April 2024)
The most recent citing publications are shown below. View all 42 publications that cite this research output on Dimensions.
Article in Journal of Investigative Dermatology (April 2024)
Article in Oncogene (January 2024)
Article in Cancer Research (December 2023)